Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial

Paller, A.S., Siegfried, E.C., Thaçi, D. et al. (22 more authors) (2020) Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial. Journal of the American Academy of Dermatology, 83 (5). pp. 1282-1293. ISSN 0190-9622

Abstract

Metadata

Authors/Creators:
  • Paller, A.S.
  • Siegfried, E.C.
  • Thaçi, D.
  • Wollenberg, A.
  • Cork, M.J. ORCID logo https://orcid.org/0000-0003-4428-2428
  • Arkwright, P.D.
  • Gooderham, M.
  • Beck, L.A.
  • Boguniewicz, M.
  • Sher, L.
  • Weisman, J.
  • O’Malley, J.T.
  • Patel, N.
  • Hardin, M.
  • Graham, N.M.H.
  • Ruddy, M.
  • Sun, X.
  • Davis, J.D.
  • Kamal, M.A.
  • Khokhar, F.A.
  • Weinreich, D.M.
  • Yancopoulos, G.D.
  • Beazley, B.
  • Bansal, A.
  • Shumel, B.
Copyright, Publisher and Additional Information: © 2020 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Atopic dermatitis; children; dupilumab; IL-4Rα; severe; pediatric
Dates:
  • Accepted: 12 June 2020
  • Published (online): 20 June 2020
  • Published: November 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 01 Jul 2020 14:33
Last Modified: 20 Oct 2020 15:04
Published Version: https://www.sciencedirect.com/science/article/pii/...
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jaad.2020.06.054
Related URLs:

Share / Export

Statistics